首页 > 市场调查报告书 > 製药

自体免疫疾病

市场调查报告书

商品编码

1820660

全球类风湿性关节炎药物市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

Global Rheumatoid Arthritis Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 107 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球类风湿性关节炎药物市场预计将经历显着扩张，预计 2025 年至 2033 年的年复合成长率(CAGR) 为 6.17%。根据市场分析，预计到 2033 年底市场规模将达到 424.3 亿美元，高于 2024 年的 247.6 亿美元。

全球类风湿关节炎 (RA) 药物市场预计将稳定成长，这得益于自体免疫疾病盛行率的上升以及标靶生物疗法的进步。改善病情的抗风湿药物 (DMARD)，包括生物製剂和 Janus 激酶 (JAK) 抑制剂，正在改善疾病管理和患者生活品质。未来的发展将着重于个人化医疗、新型药物输送系统和联合疗法。

此外，医疗基础设施的不断扩展和认知项目的不断推进，正在拓宽患者用药管道，尤其是在新兴市场。监管部门的审批和生物相似药的引入正在影响市场动态。生物标记研究和数位健康工具的进步正在增强治疗监测。随着类风湿性关节炎治疗的发展，药物市场将持续创新，提供更安全、更有效、更方便的疗法。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第 8 章：类风湿性关节炎药物公司的竞争格局

类风湿性关节炎药物市场竞争
伙伴关係/合作/协议
併购
新产品发布
其他发展

第九章：公司简介

顶级公司市占率分析
市场集中度
AbbVie Inc.

公司概况
公司收入
产品
最新动态

Johnson & Johnson Innovative Medicine

公司概况
公司收入
产品
最新动态

Amgen Inc.

公司概况
公司收入
产品
最新动态

Pfizer Inc.

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Sanofi SA

公司概况
公司收入
产品
最新动态

F. Hoffmann-La Roche Ltd.

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Bristol-Myers Squibb Company

公司概况
公司收入
产品
最新动态

Eli Lilly And Company

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

简介目录图表

Product Code: VMR112111983

Global Rheumatoid Arthritis Drugs Market is anticipated to experience remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 6.17% from 2025 to 2033. According to the market analysis, the market size is forecasted to reach USD 42.43 Billion by the end of 2033, up from USD 24.76 Billion in 2024.

The global rheumatoid arthritis (RA) drugs market is set for steady growth driven by increasing prevalence of autoimmune disorders and advancements in targeted biologic therapies. Disease-modifying antirheumatic drugs (DMARDs), including biologics and Janus kinase (JAK) inhibitors, are improving disease management and patient quality of life. Future developments will focus on personalized medicine, novel drug delivery systems, and combination therapies.

Moreover, expanding healthcare infrastructure and awareness programs are broadening patient access, especially in emerging markets. Regulatory approvals and biosimilar introductions are influencing market dynamics. Advances in biomarker research and digital health tools are enhancing treatment monitoring. As RA care evolves, the drugs market will continue to innovate, delivering safer, more effective, and accessible therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Rheumatoid Arthritis Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Disease Modifying Anti-rheumatic Drugs (DMARDs)
Biologic Response Modifiers (Biologics)

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
List of Companies Profiled in the report
AbbVie Inc., Johnson & Johnson Innovative Medicine, Amgen Inc., Pfizer Inc., Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Company, Eli Lilly and Company

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RHEUMATOID ARTHRITIS DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET ANALYSIS BY DRUG TYPE

5.1. Overview By Drug Type
5.2. Historical and Forecast Data Analysis By Drug Type
5.3. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Historic and Forecast Sales By Regions
5.4. Corticosteroids Historic and Forecast Sales By Regions
5.5. Disease Modifying Anti-rheumatic Drugs (DMARDs) Historic and Forecast Sales By Regions
5.6. Biologic Response Modifiers (Biologics) Historic and Forecast Sales By Regions

6. GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacy Historic and Forecast Sales By Regions
6.4. Retail Pharmacy Historic and Forecast Sales By Regions
6.5. Online Pharmacy Historic and Forecast Sales By Regions

7. GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RHEUMATOID ARTHRITIS DRUGS COMPANIES

8.1. Rheumatoid Arthritis Drugs Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF RHEUMATOID ARTHRITIS DRUGS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. AbbVie Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Johnson & Johnson Innovative Medicine
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Amgen Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Pfizer Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Novartis AG
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Sanofi S.A.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. F. Hoffmann-La Roche Ltd.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Merck & Co. Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Bristol-Myers Squibb Company
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Eli Lilly And Company
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Type (USD MN)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Sales By Geography (USD MN)
Corticosteroids Market Sales By Geography (USD MN)
Disease Modifying Anti-rheumatic Drugs (DMARDs) Market Sales By Geography (USD MN)
Biologic Response Modifiers (Biologics) Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Global Rheumatoid Arthritis Drugs Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Rheumatoid Arthritis Drugs Report
Market Research Process
Market Research Methodology
Global Rheumatoid Arthritis Drugs Market Size, By Regions (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Type
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By Regions
Value Chain Analysis
Global Market Analysis By Drug Type (USD MN)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Sales By Geography (USD MN)
Corticosteroids Market Sales By Geography (USD MN)
Disease Modifying Anti-rheumatic Drugs (DMARDs) Market Sales By Geography (USD MN)
Biologic Response Modifiers (Biologics) Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis